BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Invitation To Participate In A Conference Call: Procyon BioPharma Inc. (PBP.TO) To Report The Receptor And Mode-Of-Action For PCK3145, Its Lead Drug Candidate For Advanced Metastatic Prostate Cancer


10/19/2005 5:13:04 PM

MONTREAL, April 18 /CNW Telbec/ - Procyon Biopharma Inc. (TSX: PBP) invites media representatives as well as members of the financial and scientific communities to participate in a conference call. During the conference call, Mr. Hans Mader, President and Chief Executive Officer of Procyon Biopharma and Dr. Richard Béliveau from the University of Quebec in Montreal, will present the latest findings elucidating the mode-of-action and the relevant cell surface receptor of PCK3145, Procyon's therapeutic peptide for the treatment of advanced metastatic prostate cancer. The conference call will be held on Tuesday, April 19, 2005 at 9:00 am (ET). A news release will be issued on Canada Newswire (www.newswire.ca) and PR Newswire (www.prnewswire.com) prior to the event.

Read at Canada NewsWire

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES